The costs of childhood epilepsy in Italy: Comparative findings from three health care settings

Epilepsia

Volumn 42, Issue 5, 2001, Pages 641-646

  Guerrini, R ^a   Battini, R ^a   Ferrari, A R ^a   Veggiotti, P ^b   Besana, D ^c   Gobbi, G ^d   Pezzani, M ^e   Berta, E ^f   Tetto, A ^g,h   Beghi, E ^g,h   Monticelli, M L ^g   Tediosi, F ^g   Garattini, L ^g   Russo, S ^b,i   Rasmini, P ^c,i   Amadi, A ^d,i   Quarti, P ^e,i   Fabrizzi, R ⁱ  

^a UNIVERSITY OF PISA   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c C Arrigo Children's Hospital   (Italy)

^d Arcispedale Santa Maria Nuova   (Italy)

^e Unità Operativa NPI   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^h SAN GERARDO HOSPITAL   (Italy)

ⁱ UO NPI   (Italy)

Author keywords

Children; Direct costs; Epilepsy; Quality of care

Indexed keywords

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; DISEASE DURATION; DISEASE SEVERITY; DRUG COST; ELECTROPHYSIOLOGY; EPILEPSY; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITAL SERVICE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; AGE FACTORS; AMBULATORY CARE; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG COSTS; EPILEPSY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES; HEALTH SERVICES RESEARCH; HOSPITAL COSTS; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; ITALY; MALE; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX;

EID: 0035010881     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.27300.x     Document Type: Article

References (24)

1. Hauser WA, Hesdorffer D. Epilepsy: frequency, causes and consequencies. New York: Demos Press, 1990.
2. Begley CE, Annegers JF, Lairson DR, et al. Methodological issues in estimating the cost of epilepsy. Epilepsy Res 1999;33:39-55.
3. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993;34:592-6.
4. Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
5. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
6. Brunetti M, Pagano E, Garattini L. The economic cost of epilepsy: a review. It J Neurol Sci 1998:19:116-9.
7. Berto P, Tinuper P, Viaggi S, Cost-of-illness of epilepsy in Italy: data from a multicentre observational study (Episcreen). Pharmacoeconomics 2000;17:197-208.
8. Begley CE, Annegers JF, Lairson DR, et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994;35:1230-43.
9. De Zelincourt M, Buteau L, Fagnani F, Jallon P. The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Seizure 2000;9:88-95.
10. Malmgren K, Hedstrom A, Granqvist R, et al. Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy. Epilepsy Res 1996;25:199-207.
11. Murray MI, Halpern MT, Leppik IE. Cost of refractory epilepsy in adults in the USA. Epilepsy Res 1996;23:139-48.
12. Cockerell OC, Hart YM, Sander JWAS, et al. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res 1994;18:249-60.
13. van Hout B, Gagnon D, Souetre E, et al. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 1997;38:1221-6.
14. Jacoby A, Buck D, Baker G, et al.Uptake and costs for epilepsy: findings from a U.K. regional study. Epilepsia 1998;39:776-86.
15. Swingler RJ, Davidson DLW, Roberts RC, et al. The cost of epilepsy in patients attending a specialist epilepsy service. Seizure 1994;3:115-20.
16. Hughes D, Cockerell OC. A cost minimization study comparing vigabatrin, lamotrigine and gabapentin for the treatment of intractable partial epilepsy. Seizure 1996;5:89-95.
17. Markowitz MA, Mauskopf JA, Halpern MT. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy. Neurology 1998;51:1026-33.
18. Kriel RL, Cloyd JC, Hadsall RS, et al. Home use of rectal diazepam for cluster and prolonged seizures: efficacy, adverse reactions, quality of life and cost analysis. Pediatr Neurol 1991;7:13-7.
19. Mirza WU, Credeur LJ, Penry JK. Results of antiepileptic drug reduction in patients with multiple handicaps and epilepsy. Drug Invest 1993;5:320-6.
20. Espinosa RL, Libarnes RL, Perez MC. Carbamazepine for status epilepticus. Philipp J Intern Med 1993;31:71-7.
21. Halpern M, Rentz A, Murray M. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates. Neuroepidemiology 2000;19:87-99.
22. Lesser RP. The role of epilepsy centers in delivering care to patients with intractable epilepsy. Neurology 1994;44:1347-52.
23. Johnson WG. The costs of epilepsy and cost-based evaluations of anticonvulsants. Pharmacoeconomics 1997;12:446-59.
24. Annegers JF, Beghi E, Begley CE. Cost of epilepsy: contrast of methodologies in United States and European studies. Epilepsia 1999;40(suppl. 8):14-9.